Neurologist Current Events | Neurologist News | 3
|
|
|
Sort By:
Page Views | Date |
Fewer injection site reactions in patients using Avonex
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon® (interferon beta-1b), Copaxone® (glatiramer Acetate) or Rebif ®... view more... (2009-09-11)
Michigan hospital launches gene therapy study for Parkinson's disease
A Michigan hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. view more (2009-10-07)
Damage from oxygen may be one cause of Parkinson's disease
Research by neuroscientists at the University of Virginia Health System shows that oxygen free radicals are damaging proteins in mitochondria, the tiny cellular 'batteries' of brain cells. view more (2006-05-17)
Mice models developed at UCSD to benefit patients with multiple system atrophy
Researchers at the University of California, San Diego (UCSD) School of Medicine have developed a series of transgenic mouse models of multiple system atrophy, a progressive, fatal neurological disorder. view more (2005-11-17)
Spinal cord injury research hampered by animal models, says new study
Research on traumatic spinal cord injuries is hampered by a reliance on animal experiments that don't accurately predict human outcomes, says a new study in the upcoming edition of the peer-reviewed journal Reviews in the Neurosciences. The review was written by scientists with the Physicians Committee for Responsible Medicine. view more (2008-04-29)
Seizure drug enhances sleep for women with hot flashes
Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health. view more (2009-09-09)
Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States. view more (2009-09-22)
Mayo Clinic study finds weight loss precedes dementia diagnosis in women
Mayo Clinic researchers have found that women who develop dementia experience a decline in weight as many as 10 years prior to the onset of memory loss, compared to peers who do not develop dementia. view more (2006-07-17)
Two copies of G2019S Parkinson's gene mutation doesn't lead to more severe disease
A group of Parkinson's disease researchers concluded there are no observable differences between those who have two copies of the most common mutation of the recently discovered LRRK2 gene and those who have only one copy. view more (2006-09-12)
A fading sense of smell may signal onset of Parkinson's disease
Many individuals with Parkinson's disease are able to recall losing their sense of smell well before the onset of more commonly recognized symptoms such as tremors, impaired dexterity, speech problems, memory loss and decreased cognitive ability. view more (2008-12-12)
|
|
|
|
Sort By:
Page Views | Date |
|
